Navigation Links
Recent breakthroughs in cocoa flavanol research discussed by European research consortium and expert panel
Date:1/24/2013

Brussels, Belgium (January 24, 2013) --- Over 50 leading experts will meet today in Brussels, Belgium, to discuss recent breakthroughs in the field of cocoa flavanol research and the key findings of FLAVIOLA an EU-funded consortium dedicated to state-of-the-art research into flavanols, their health benefits and potential applications. Members of the FLAVIOLA consortium will be joined by a number of international researchers to review the outcomes of FLAVIOLA's research and their potential implications on cocoa flavanol-based applications and potential dietary recommendations for flavanol intake.

The workshop, entitled FLAVIOLA International Workshop on Flavanols in Cardiovascular Health, will feature presentations on the project outcomes and wider scientific implications, and will conclude with a panel discussion by leading international scientific and medical experts. Workshop proceedings will be developed following the meeting in order to publically communicate the collective views of the FLAVIOLA consortium and experts in the field.

"We now have a strong understanding of flavanols' cardiovascular and circulatory health benefits and the past few years have seen a number of significant research advances many of which have been driven by FLAVIOLA scientists," commented Professor Malte Kelm, FLAVIOLA Scientific Director and Professor and Chairman of the Department of Cardiology, Pulmonary Diseases, Vascular Medicine, and Intensive Care Medicine at Heinrich-Heine University, Dsseldorf. "This multidisciplinary research has focused on linking the chemistry of flavanols with their benefits for human health and has deeply improved our understanding of the function, delivery and potential health applications of these unique and fascinating compounds."

FLAVIOLA leverages the latest innovations in chemistry, cardiovascular function analysis, food processing technology, and analytics to drive forward investigations into the biological action of flavanols and apply this knowledge in the development of evidence-based dietary recommendations and innovative products. Specifically, FLAVIOLA focuses on providing new insights in four key areas - the analysis of flavanols, flavanol consumption, the impact of flavanols in healthy people, and the potential mechanisms of action of flavanols.

Recent research by FLAVIOLA scientists has shed new light on the types and amounts of flavanols in cocoa, as well as the impact of food processing and manufacturing on the flavanol content of certain food products. New findings have also advanced understanding of what happens to flavanols in the human body following consumption, and provided insights into the mechanisms of action that underlie the biological effects of this phytonutrient. FLAVIOLA researchers have also compiled a comprehensive database of the amounts and types of flavanols consumed in 14 countries across the European Union. This will enable better interpretation of dietary intervention studies and clearer associations between flavanol consumption and health and disease.

"By advancing our knowledge of the health benefits, function and delivery of flavanols, FLAVIOLA has the potential to have a far-reaching impact on public health," said Professor Marc Merx, FLAVIOLA Coordinator and Professor at the Department of Cardiology, Pulmonary Diseases, Vascular Medicine, and Intensive Care Medicine, Heinrich-Heine University, Dsseldorf. "The breadth and quality of the research undertaken by FLAVIOLA would not have been possible without the diverse partners from across Europe that were brought together for this project."


'/>"/>
Contact: Anneka Munsch
anneka.munsch@cnc-communications.com
44-781-039-5317
FLAVIOLA
Source:Eurekalert

Related biology news :

1. From 503-million-year-old fungi to recent earthquakes: New Geology posted ahead of print
2. GEN reports on recent progress in Alzheimers research
3. Recent studies bring fossils and genes together to piece together evolutionary history
4. Invading species can extinguish native plants despite recent reports
5. Recent study suggests bats are reservoir for ebola virus in Bangladesh
6. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
7. Scientists advance field of research with publication of newly validated method for analyzing flavanols in cocoa
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
10. Research reveals first evidence of hunting by prehistoric Ohioans
11. Diabetes Research Institute develops oxygen-generating biomaterial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... LabKey and collaborator Just Biotherapeutics, ... solution, LabKey Biologics . Built in collaboration with Just and designed with ... provides drug research teams tools for biological entity registration, assay data integration, and ...
(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... fight against cancer, autoimmune disease and more through a single-cell precision engineering platform, ... proteomics analysis platform developed in the laboratory of Dr. James Heath at ...
(Date:3/27/2017)... ROCKVILLE, Md. , March 27, 2017 /PRNewswire/ ... $108.5 billion for 2016, according to a new ... patients, medical lab testing is performed to evaluate ... determine individual therapy, among other reasons.  The healthcare ... Services Market , provides an overview of ...
Breaking Biology Technology: